Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Neoplasms|Breast Cancer
Interventions: DRUG: Pembrolizumab|DRUG: Mifepristone
Sponsor: University of Chicago